KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis

被引：0

作者：

Tanja Limberger

Michaela Schlederer

Karolina Trachtová

Ines Garces de los Fayos Alonso

Jiaye Yang

Sandra Högler

Christina Sternberg

Vojtech Bystry

Jan Oppelt

Boris Tichý

Margit Schmeidl

Petra Kodajova

Anton Jäger

Heidi A. Neubauer

Monika Oberhuber

Belinda S. Schmalzbauer

Sarka Pospisilova

Helmut Dolznig

Wolfgang Wadsak

Zoran Culig

Suzanne D. Turner

Gerda Egger

Sabine Lagger

Lukas Kenner

机构：

[1] Medical University of Vienna,Division of Experimental and Translational Pathology, Department of Pathology

[2] CBmed-Center for Biomarker Research in Medicine GmbH,Division of Nuclear Medicine, Department of Biomedical Imaging and Image

[3] Central European Institute of Technology,Guided Therapy

[4] Masaryk University,Unit of Laboratory Animal Pathology

[5] Christian Doppler Laboratory for Applied Metabolomics,Institute of Biochemistry

[6] Medical University of Vienna,Institute of Animal Breeding and Genetics

[7] University of Veterinary Medicine Vienna,Institute of Pharmacology and Toxicology

[8] Christian-Albrechts-University Kiel,Institute of Medical Genetics

[9] University of Veterinary Medicine Vienna,Department of Urology

[10] University of Veterinary Medicine Vienna,Department of Pathology

[11] Medical University of Vienna,undefined

[12] Innsbruck Medical University,undefined

[13] University Cambridge,undefined

[14] CEITEC,undefined

[15] Masaryk University,undefined

[16] Ludwig Boltzmann Institute Applied Diagnostics,undefined

来源：

Molecular Cancer | / 21卷

关键词：

Prostate cancer; Senescence; Metastasis; KMT2C; MYC; p16;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis
Limberger, Tanja
Schlederer, Michaela
Trachtova, Karolina
Alonso, Ines Garces de los Fayos
Yang, Jiaye
Hoegler, Sandra
Sternberg, Christina
Bystry, Vojtech
Oppelt, Jan
Tichy, Boris
Schmeidl, Margit
Kodajova, Petra
Jaeger, Anton
Neubauer, Heidi A.
Oberhuber, Monika
Schmalzbauer, Belinda S.
Pospisilova, Sarka
Dolznig, Helmut
Wadsak, Wolfgang
Culig, Zoran
Turner, Suzanne D.
Egger, Gerda
Lagger, Sabine
Kenner, Lukas
[J]. MOLECULAR CANCER, 2022, 21 (01)
[2] Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer
Lian, Jianpo
Xu, Chengdang
Chen, Xi
Huang, Shengsong
Wu, Denglong
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1627 - 1640
[3] Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer
Jianpo Lian
Chengdang Xu
Xi Chen
Shengsong Huang
Denglong Wu
[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1627 - 1640
[4] Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer
Chen, Xiaoqing
Zhang, Guochun
Chen, Bo
Wang, Yulei
Guo, Liping
Cao, Li
Ren, Chongyang
Wen, Lingzhu
Liao, Ning
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
[5] STAT3 regulated ARF expression suppresses prostate cancer metastasis
Jan Pencik
Michaela Schlederer
Wolfgang Gruber
Christine Unger
Steven M. Walker
Athena Chalaris
Isabelle J. Marié
Melanie R. Hassler
Tahereh Javaheri
Osman Aksoy
Jaine K. Blayney
Nicole Prutsch
Anna Skucha
Merima Herac
Oliver H. Krämer
Peter Mazal
Florian Grebien
Gerda Egger
Valeria Poli
Wolfgang Mikulits
Robert Eferl
Harald Esterbauer
Richard Kennedy
Falko Fend
Marcus Scharpf
Martin Braun
Sven Perner
David E. Levy
Tim Malcolm
Suzanne D. Turner
Andrea Haitel
Martin Susani
Ali Moazzami
Stefan Rose-John
Fritz Aberger
Olaf Merkel
Richard Moriggl
Zoran Culig
Helmut Dolznig
Lukas Kenner
[J]. Nature Communications, 6
[6] STAT3 regulated ARF expression suppresses prostate cancer metastasis
Pencik, Jan
Schlederer, Michaela
Gruber, Wolfgang
Unger, Christine
Walker, Steven M.
Chalaris, Athena
Marie, Isabelle J.
Hassler, Melanie R.
Javaheri, Tahereh
Aksoy, Osman
Blayney, Jaine K.
Prutsch, Nicole
Skucha, Anna
Herac, Merima
Kraemer, Oliver H.
Mazal, Peter
Grebien, Florian
Egger, Gerda
Poli, Valeria
Mikulits, Wolfgang
Eferl, Robert
Esterbauer, Harald
Kennedy, Richard
Fend, Falko
Scharpf, Marcus
Braun, Martin
Perner, Sven
Levy, David E.
Malcolm, Tim
Turner, Suzanne D.
Haitel, Andrea
Susani, Martin
Moazzami, Ali
Rose-John, Stefan
Aberger, Fritz
Merkel, Olaf
Moriggl, Richard
Culig, Zoran
Dolznig, Helmut
Kenner, Lukas
[J]. NATURE COMMUNICATIONS, 2015, 6
[7] H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma
Bosgana, Pinelopi
Nikou, Sophia
Dimitrakopoulos, Foteinos-Ioannis
Logotheti, Souzana
Tzelepi, Vasiliki
Kalophonos, Charalambos
Bravou, Vasiliki
Kourea, Eleni
Sampsonas, Fotios
Zolota, Vassiliki
[J]. CURRENT MOLECULAR PHARMACOLOGY, 2021, 14 (06) : 1028 - 1036
[8] Histone modification by Kmt2c and Kmt2d regulate metastasis in triple-negative breast cancer in vivo.
Seehawer, Marco
Li, Zheqi
Nishida, Jun
Cejas, Paloma
Reiter, Andrew
Goldman, Seth
Foidart, Pierre
Rojas, Ernesto
Papanastasiou, Malvina
Adelman, Karen
Long, Henry
Polyak, Kornelia
[J]. CANCER RESEARCH, 2022, 82 (23)
[9] Pan-cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy
Cao, Wei
Xie, Yawen
Cai, Li
Wang, Mengqing
Chen, Zhuoying
Wang, Ziteng
Xv, Jiajia
Wang, Yuqing
Li, Rong
Liu, Xuesong
Wang, Wenliang
[J]. ONCOLOGY LETTERS, 2024, 28 (03)
[10] The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
Rampias, Theodoros
Karagiannis, Dimitris
Avgeris, Margaritis
Polyzos, Alexander
Kokkalis, Antonis
Kanaki, Zoi
Kousidou, Evgenia
Tzetis, Maria
Kanavakis, Emmanouil
Stravodimos, Konstantinos
Manola, Kalliopi N.
Pantelias, Gabriel E.
Scorilas, Andreas
Klinakis, Apostolos
[J]. EMBO REPORTS, 2019, 20 (03)

← 1 2 3 4 5 →